Literature DB >> 29680992

Comparison of mucosal and mucoperiosteal wound cover for the treatment of medication-related osteonecrosis of the jaw lesions: a retrospective cohort study.

Nicola Nonnenmühlen1,2, A Burnic3, A Bartella3, B Lethaus3, F Gerhards3, O Ristow4, C Pautke5,6, F Hölzle3, T Steiner3.   

Abstract

OBJECTIVES: Actually, there is no detailed guidance on how to deal with wound closure after surgical removal of medication-related osteonecrosis of the jaw (MRONJ) lesions. This study attempts to compare the difference in outcome between the mucosal and the mucoperiosteal flap closure after surgery. PATIENTS AND METHODS: In this retrospective monocentric cohort study, patients (n = 61; 35 female/26 male) suffering from MRONJ and requiring surgical therapy at the University of Aachen between 2013 and 2015 were included. Due to intra-institutional variances, one group was treated with the mucosal, the other group with the mucoperiosteal technique. The success rate, i.e., mucosal closure and no relapse at the point of follow-up, was evaluated and compared. All patients were clinically investigated for the postoperative follow-up during a special consultation appointment.
RESULTS: The success rates between the different techniques after 2 years follow-up were very similar. In the group of mucosal wound closure, 22 of 29 (75.86%) patients revealed mucosal integrity without signs of MRONJ. The rate in the mucoperiosteal wound closure group was almost identical (24 of 32 (75%)).
CONCLUSION: No differences in the success rates between the two different techniques could be evaluated. CLINICAL RELEVANCE: The results of this study suggest that the complete removal of the necrotic bone might have a higher impact on the success rates than the technique of the wound closure. Due to the fact that the mucoperiosteal wound closure technique offers a better overview of the extent of the MRONJ lesion, the authors advise to use this technique.

Entities:  

Keywords:  Bisphosphonate; MRONJ; Osteonecrosis; Retrospective cohort study; Surgical treatment

Mesh:

Year:  2018        PMID: 29680992     DOI: 10.1007/s00784-018-2443-9

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  2 in total

1.  Adipose-derived stem cells prevent the onset of bisphosphonate-related osteonecrosis of the jaw through transforming growth factor β-1-mediated gingival wound healing.

Authors:  Xiaolong Zang; Linhai He; Lu Zhao; Yang He; E Xiao; Yi Zhang
Journal:  Stem Cell Res Ther       Date:  2019-06-13       Impact factor: 6.832

2.  The role of M1 and M2 macrophage polarization in progression of medication-related osteonecrosis of the jaw.

Authors:  Sotirios Tetradis; Christos Perisanidis; Nikolaos G Nikitakis; Polytimi Paschalidi; Ioannis Gkouveris; Akrivoula Soundia; Evangelos Kalfarentzos; Emmanouil Vardas; Maria Georgaki; Georgios Kostakis; Boban M Erovic
Journal:  Clin Oral Investig       Date:  2020-09-22       Impact factor: 3.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.